^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

phenelzine

Associations
Company:
Generic mfg.
Drug class:
Monoamine oxidase inhibitor
Associations
6ms
Enhancing immunotherapy efficacy in NSCLC through the combined use of phenelzine and Akkermansia muciniphila to regulate gut microbial metabolite 5-HIAA. (PubMed, J Immunother Cancer)
Our investigations reveal that alterations in gut microbial composition leading to increased 5-HIAA synthesis can negatively impact CD8+ T cell functionality and the success of immunotherapy. The combination of Phe and AKK supplementation holds potential for optimizing immunotherapy efficacy.
Journal
|
CD8 (cluster of differentiation 8)
|
phenelzine
10ms
Biomarker-driven drug repurposing for NAFLD-associated hepatocellular carcinoma using machine learning integrated ensemble feature selection. (PubMed, Front Bioinform)
Through drug repurposing, 81 candidate drugs were found to be effective against these markers genes, with Diosmin, Esculin, Lapatinib, and Phenelzine as the best candidates screened through molecular docking and MMGBSA. The consensus derived from multiple methods enhances the accuracy of identifying relevant robust biomarkers for NAFLD-associated HCC. The use of these biomarkers in a multiphase drug repurposing strategy highlights potential therapeutic options for early intervention, which is essential to stop disease progression and improve outcomes.
Journal
|
ABCB1 (ATP Binding Cassette Subfamily B Member 1)
|
lapatinib • phenelzine
over1year
Serotonin Availability Shapes the Effects of Phenelzine on Inflammatory Response and Gene Expression in Macrophages. (PubMed, Cureus)
These effects were significantly influenced by the concentration of available serotonin. Conclusions Our study demonstrates that various mechanisms, including AHR activation, modulation of reactive oxygen and nitrogen species production, and others, in addition to the increased availability of serotonin due to phenelzine treatment, can significantly influence the inflammatory state.
Journal
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL10 (Interleukin 10) • CYP1B1 (Cytochrome P450 Family 1 Subfamily B Member 1)
|
phenelzine
over1year
Precision Care for Major Depressive Disorder (clinicaltrials.gov)
P4, N=150, Enrolling by invitation, University of California, San Francisco | Not yet recruiting --> Enrolling by invitation
Enrollment open
|
phenelzine
over1year
Precision Care for Major Depressive Disorder (clinicaltrials.gov)
P4, N=150, Not yet recruiting, University of California, San Francisco
New P4 trial
|
phenelzine
over2years
Synthesis and anti-cancer potential of potent peripheral MAOA inhibitors designed to limit blood:brain penetration. (PubMed, Bioorg Med Chem)
A Phase II Clinical Trial has demonstrated the therapeutic effects of the irreversible nonselective MAOi phenelzine for prostate cancer...However, introduction of a polar 2-hydroxy in the propyl chain retained the highly selective MAOA inhibition and cancer cell cytotoxicity of clorgyline while reducing its CNS score from 2 to 0. We believe that these results identify a new class of peripherally directed MAOIs that may allow safer therapeutic targeting of MAOA for a variety of anti-cancer and anti-inflammatory indications.
Journal
|
MAOA (Monoamine Oxidase A)
|
Xtandi (enzalutamide) • phenelzine
3years
Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer (clinicaltrials.gov)
P2, N=26, Completed, University of Southern California | Active, not recruiting --> Completed
Trial completion • Metastases
|
CAST (Calpastatin)
|
phenelzine
over3years
KDM1A inhibition increases UVA toxicity and enhances photodynamic therapy efficacy. (PubMed, Photodermatol Photoimmunol Photomed)
KDM1A is a regulator of cellular UV response, and KDM1A inhibition can improve PDT efficacy.
Journal
|
KDM1A (Lysine Demethylase 1A)
|
KDM1A overexpression • KDM1A expression
|
phenelzine
over5years
The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer. (PubMed, Nat Commun)
Our findings suggest that Enz-increased ARv7 expression can transcriptionally enhance MAO-A expression resulting in Enz resistance via altering the hypoxia HIF-1α signals. Together, our results show that targeting the Enz/ARv7/MAO-A signaling with the antidepressants phenelzine or clorgyline can restore Enz sensitivity to suppress EnzR cell growth, which may indicate that these antidepression drugs can overcome the Enz resistance to further suppress the EnzR CRPC.
Journal
|
HIF1A (Hypoxia inducible factor 1, alpha subunit)
|
AR splice variant 7 • HIF1A expression
|
Xtandi (enzalutamide) • phenelzine